Cencora, Inc. (COR)

223,92 -2,82 (-1,24%) A partir del 03:57PM EDT. Mercado abierto.

Cencora, Inc.

1 West First Avenue
Conshohocken, PA 19428-1800
United States
610 727 7000
https://www.cencora.com

Sector(es): Healthcare
Sector: Medical Distribution
Empleados a tiempo completo: 46.000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Steven H. Collis	Chairman, President & CEO	5,01M	13,79M	1961
Mr. James F. Cleary Jr.	Executive VP & CFO	1,95M	3,8M	1963
Dr. Robert P. Mauch Ph.D., PharmD	Executive VP & COO	2,7M	N/A	1967
Ms. Gina K. Clark	Executive VP and Chief Communications & Administration Officer	1,57M	5,01M	1957
Ms. Elizabeth S. Campbell	Executive VP & Chief Legal Officer	1,63M	318,67k	1975
Mr. Lazarus Krikorian	Senior VP, Chief Accounting Officer & Corporate Controller	N/A	N/A	1965
Bennett S. Murphy	Senior Vice President of Investor Relations	N/A	N/A	N/A
Ms. Jennifer E. Dubas	Senior VP & Chief Compliance Officer	N/A	N/A	N/A
Ms. Silvana Battaglia	Executive VP & Chief Human Resources Officer	1,58M	N/A	1968
Ms. Leslie E. Donato	Executive VP & Chief Strategy Officer	N/A	N/A	1970

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Gobierno corporativo

El ISS Governance QualityScore de Cencora, Inc., a día 1 de mayo de 2024, es 3. Las puntuaciones base son Auditoría: 2; Tablero: 5; Derechos de los accionistas: 6; Compensación: 3.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.